Back
Phathom Pharmaceuticals Vs. 4D Molecular Therapeutics Industry Stock Comparison
Buy
67
PHAT
Phathom Pharmaceuticals
Last Price:
9.19
Seasonality Move:
-5.3%
Sell
16
FDMT
4D Molecular Therapeutics
Last Price:
23.21
Seasonality Move:
-20.46%
Buy
67
Phathom Pharmaceuticals (PHAT)
is a Buy
Is Phathom Pharmaceuticals a Buy, Sell or Hold?
- The current Phathom Pharmaceuticals [PHAT] share price is $9.18. The Score for PHAT is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
- PHAT is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
16
4D Molecular Therapeutics (FDMT)
is a Sell
Is 4D Molecular Therapeutics a Buy, Sell or Hold?
- The current 4D Molecular Therapeutics [FDMT] share price is $23.25. The Score for FDMT is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
- FDMT is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
PHAT Stock Price Chart
What is Phathom Pharmaceuticals's stock price today?
-
The Phathom Pharmaceuticals share price today is $9.18
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PHAT is experiencing slight selling pressure.
FDMT Stock Price Chart
What is 4D Molecular Therapeutics's stock price today?
-
The 4D Molecular Therapeutics share price today is $23.25
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FDMT is experiencing slight selling pressure.
PHAT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.19 | Sell |
Relative Strength Index (14 RSI): | 43.31 | Sell |
Chaikin Money Flow: | -23658 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (9.35 - 11.07) | Sell |
Bollinger Bands (100): | (7.48 - 10.2) | Buy |
FDMT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.44 | Sell |
Relative Strength Index (14 RSI): | 34.11 | Sell |
Chaikin Money Flow: | -30640 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (24.57 - 31.31) | Sell |
Bollinger Bands (100): | (18.43 - 29.93) | Sell |
PHAT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 9.22 | Sell |
20-day SMA: | 10.08 | Sell |
50-day SMA: | 9.78 | Sell |
200-day SMA: | 10.14 | Sell |
8-day EMA: | 9.33 | Sell |
20-day EMA: | 9.69 | Sell |
50-day EMA: | 9.52 | Sell |
200-day EMA: | 9.71 | Sell |
FDMT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 24.7 | Sell |
20-day SMA: | 26.48 | Sell |
50-day SMA: | 28.52 | Sell |
200-day SMA: | 19.19 | Buy |
8-day EMA: | 24.68 | Sell |
20-day EMA: | 26.35 | Sell |
50-day EMA: | 26.76 | Sell |
200-day EMA: | 21.52 | Buy |
Phathom Pharmaceuticals Earnings Growth & PHAT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.12 per share, an increase next quarter of $0.15 per share, a decrease this year of $0.75 per share, and an increase next year of $1.24 per share.
4D Molecular Therapeutics Earnings Growth & FDMT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.17 per share, a decrease next quarter of $0.11 per share, a decrease this year of $0.38 per share, and a decrease next year of $0.32 per share.
Phathom Pharmaceuticals Technical Analysis
Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
4D Molecular Therapeutics Technical Analysis
Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |